Please login to the form below

Not currently logged in
Email:
Password:

Astellas taps Lilly for comms chief

Jeffrey Winton appointed first chief communications officer
Jeffrey Winton

Astellas US has announced that Lilly's Jeffrey Winton will be the company's first senior vice president, chief communications officer.

Winton was vice president and head, global communications at Lilly, belonging to the global corporate affairs leadership team.

He will be responsible for corporate branding and reputation management in the US, reporting to Masao Yoshida, chief executive officer of Tokyo-based parent company Astellas Pharma. He has more than 30 years of communications experience in the pharmaceutical industry.

Prior to joining Lilly, Winton held senior communications roles at major global pharmaceutical companies such as Schering-Plough and Pharmacia. He has a degree in life sciences from Cornell University in Ithaca, New York.

"I am pleased to add Jeff to our senior management team at Astellas," said Yoshida. "He brings with him the broad industry expertise and experience we are looking for to help propel the Astellas brand in the Americas."


5th November 2013

From: PME

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need...
JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...